Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2018-02-16, Stock:ABBV, The news for the past five days is as follows:
2018-02-09: NEWS1: What Drove Pfizer’s 4Q17 Growth?.NEWS2: Amgen’s Neulasta and Enbrel in 4Q17 and 2017.NEWS3: See what the IHS Markit Score report has to say about AbbVie Inc..NEWS4: How Did Pfizer’s Geographical Regions Perform in 4Q17?.NEWS5: Mavyret Is Expected to Boost AbbVie’s Hepatitis C Revenue in 2018.
2018-02-12: NEWS1: Is AbbVie or Vertex Pharmaceuticals the Better Buy Now?.NEWS2: Is AbbVie or Vertex Pharmaceuticals the Better Buy Now?.NEWS3: 5 Solid Dividend Growth Stocks Amid Rising Rates.NEWS4: 5 Solid Dividend Growth Stocks Amid Rising Rates.NEWS5: Is AbbVie or Vertex Pharmaceuticals the Better Buy Now?.NEWS6: 5 Solid Dividend Growth Stocks Amid Rising Rates.NEWS7: 5 Solid Dividend Growth Stocks Amid Rising Rates.NEWS8: These 3 Drugs Are Critical to AbbVie's Success.NEWS9: These 3 Drugs Are Critical to AbbVie's Success.NEWS10: AbbVie Showcases New, Late-Breaking Investigational Data at 2018 American Academy of Dermatology (AAD) Annual Meeting.NEWS11: These 3 Drugs Are Critical to AbbVie&apos;s Success.NEWS12: Is AbbVie Inc’s (NYSE:ABBV) ROE Of 93.77% Sustainable?.
2018-02-13: NEWS1: Zacks.com highlights: Jones Lang LaSalle, Intel, Dollar General, AbbVie and Owens Corning.NEWS2: Zacks.com highlights: Jones Lang LaSalle, Intel, Dollar General, AbbVie and Owens Corning.NEWS3: Better Buy: Eli Lilly and Company vs. Johnson & Johnson.NEWS4: Better Buy: Eli Lilly and Company vs. Johnson & Johnson.NEWS5: Bristol-Myers Squibb’s Virology Products in 4Q17.NEWS6: Zacks.com highlights: Jones Lang LaSalle, Intel, Dollar General, AbbVie and Owens Corning.
2018-02-14: NEWS1: AbbVie Appears Ready to Start a New Advance at Any Time.NEWS2: Lilly's Taltz Positive in Phase III Label Expansion Study.NEWS3: Lilly's Taltz Positive in Phase III Label Expansion Study.NEWS4: MTUM, BA, ABBV, C: ETF Inflow Alert.NEWS5: MTUM, BA, ABBV, C: ETF Inflow Alert.NEWS6: Inside Pfizer’s Inflammation and Immunology Portfolio Performances in 2017.NEWS7: Lilly&apos;s Taltz Positive in Phase III Label Expansion Study.NEWS8: 3 Top Stocks You Can Buy and Hold for the Next Decade.NEWS9: 3 Top Stocks You Can Buy and Hold for the Next Decade.NEWS10: Bristol-Myers Squibb’s Orencia and Other Brands in 4Q17.NEWS11: 3 Top Stocks You Can Buy and Hold for the Next Decade.NEWS12: 3 Dividend Stocks for In-the-Know Investors.NEWS13: 3 Dividend Stocks for In-the-Know Investors.NEWS14: 3 Dividend Stocks for In-the-Know Investors.NEWS15: Is Now a Good Time to Buy AbbVie?.NEWS16: Is Now a Good Time to Buy AbbVie?.NEWS17: Is Now a Good Time to Buy AbbVie?.
2018-02-15: NEWS1: AbbVie Stock Rises After Increasing Dividend By 35%.NEWS2: AbbVie to buy back $10 billion of shares, raises dividend.NEWS3: 5 Cheap Dividend Stocks With Growing Payouts.NEWS4: 6 Healthcare Stocks We Think Deserve Gold Medals (Hint: One's a Marijuana Stock).NEWS5: 6 Healthcare Stocks We Think Deserve Gold Medals (Hint: One's a Marijuana Stock).NEWS6: AbbVie to buy back $10 billion of shares, raises dividend.NEWS7: AbbVie to buy back $10 billion of shares, raises dividend.NEWS8: AbbVie stock rises after dividend boosted 35%, new $10 billion buyback program.NEWS9: AbbVie Increases Dividend and Announces New Stock Repurchase Program.NEWS10: How Analysts View Bristol-Myers Squibb after Its 4Q17 Earnings.NEWS11: [$$] AbbVie shares the wealth with dividend boost, $10bn in buybacks.

Answer: Rise